• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢癌细胞系中的胶原酶表达。

Collagenase expression in ovarian cancer cell lines.

作者信息

Moore D H, Allison B, Look K Y, Sutton G P, Bigsby R M

机构信息

Department of Obstetrics and Gynecology, Indiana University Medical Center, Indianapolis 46202, USA.

出版信息

Gynecol Oncol. 1997 Apr;65(1):78-82. doi: 10.1006/gyno.1997.4628.

DOI:10.1006/gyno.1997.4628
PMID:9103395
Abstract

BACKGROUND

There are several distinct forms of the matrix metalloproteinases (MMP) that degrade collagen in the extracellular matrix. Most involved in the metastatic process are collagenases exhibiting specificity for type IV collagen, the collagen that makes up the backbone of the basement membrane. We chose to examine the expression of one type IV collagenase, MMP-9, in several ovarian cancer cell lines.

METHODS

Under the influence of phorbol esters such as TPA, the fibrosarcoma cell line HT1080 is known to express MMP-9. We examined the effect of TPA on MMP-9 expression with Northern analysis, and on MMP-9 collagenase activity with polyacrylamide gel electrophoresis-zymography, in HT1080 cells (positive control) and in six ovarian cancer cell lines: Hey, HeyA8, CAOV3, PA-1, SKOV3, and OVCAR3. Cells were grown to 70% confluence and the growth medium was changed to a serum-free medium for 24 hr. Cells were then treated with 12 ng/mL TPA or its vehicle for an additional 24 hr. Medium was collected for PAGE-zymographic analysis. The cells were lysed and their RNA collected for Northern analysis.

RESULTS

PA-1, a teratocarcinoma, expressed more than 10-fold the amount of RNA for MMP-9 than the other lines following TPA treatment. Both Northern analysis and zymography showed that four of the six ovarian cell lines responded to TPA with increased collagenase expression and activity. The other two cell lines showed no MMP-9 activity either before or after TPA treatment.

CONCLUSIONS

These results suggest that ovarian cancer cell lines express collagenase and that this expression may be regulated by phorbol esters which activate the protein kinase C pathway.

摘要

背景

基质金属蛋白酶(MMP)有几种不同形式,可降解细胞外基质中的胶原蛋白。参与转移过程的大多数是对IV型胶原具有特异性的胶原酶,IV型胶原构成基底膜的骨架。我们选择检测几种卵巢癌细胞系中一种IV型胶原酶MMP - 9的表达。

方法

在佛波酯如TPA的影响下,已知纤维肉瘤细胞系HT1080表达MMP - 9。我们用Northern分析检测TPA对HT1080细胞(阳性对照)和六种卵巢癌细胞系(Hey、HeyA8、CAOV3、PA - 1、SKOV3和OVCAR3)中MMP - 9表达的影响,并用聚丙烯酰胺凝胶电泳酶谱法检测TPA对MMP - 9胶原酶活性的影响。细胞生长至70%汇合,将生长培养基换成无血清培养基24小时。然后用12 ng/mL TPA或其溶剂再处理细胞24小时。收集培养基进行PAGE - 酶谱分析。裂解细胞并收集其RNA进行Northern分析。

结果

畸胎瘤细胞系PA - 1在TPA处理后,MMP - 9的RNA表达量比其他细胞系高出10倍以上。Northern分析和酶谱分析均显示,六个卵巢细胞系中有四个对TPA有反应,胶原酶表达和活性增加。另外两个细胞系在TPA处理前后均未显示MMP - 9活性。

结论

这些结果表明卵巢癌细胞系表达胶原酶,且这种表达可能受激活蛋白激酶C途径的佛波酯调控。

相似文献

1
Collagenase expression in ovarian cancer cell lines.卵巢癌细胞系中的胶原酶表达。
Gynecol Oncol. 1997 Apr;65(1):78-82. doi: 10.1006/gyno.1997.4628.
2
Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.佛波酯和细胞因子对肿瘤及正常细胞系中基质金属蛋白酶和金属蛋白酶组织抑制剂表达的影响。
Invasion Metastasis. 1992;12(3-4):168-84.
3
Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells.熊果酸的抗侵袭活性与HT1080人纤维肉瘤细胞中基质金属蛋白酶-9(MMP-9)表达的降低相关。
Cancer Res. 1996 May 15;56(10):2281-4.
4
Invasiveness and MMP expression in pancreatic carcinoma.胰腺癌的侵袭性与基质金属蛋白酶表达
J Surg Res. 2001 Jun 1;98(1):33-9. doi: 10.1006/jsre.2001.6150.
5
Cyclic AMP-regulated synthesis of the tissue inhibitors of metalloproteinases suppresses the invasive potential of the human fibrosarcoma cell line HT1080.环磷酸腺苷调节的金属蛋白酶组织抑制剂合成可抑制人纤维肉瘤细胞系HT1080的侵袭潜能。
Cancer Res. 1995 Jul 1;55(13):2927-35.
6
Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.口腔鳞状细胞癌细胞通过膜型I基质金属蛋白酶介导的I型胶原蛋白降解
Cancer Res. 2001 Aug 15;61(16):6264-75.
7
Stimulation of the 92-kD type IV collagenase promoter and enzyme expression in human melanoma cells.人黑色素瘤细胞中92-kD IV型胶原酶启动子的刺激及酶表达
Invasion Metastasis. 1993;13(6):289-300.
8
Prominent expression of metalloproteinases in early stages of ovarian tumorigenesis.金属蛋白酶在卵巢肿瘤发生早期的显著表达。
Mol Carcinog. 2007 Feb;46(2):130-43. doi: 10.1002/mc.20273.
9
Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.正常个体以及急性和慢性髓系白血病或骨髓增生异常综合征患者的骨髓单个核细胞产生基质金属蛋白酶的情况。
Clin Cancer Res. 1999 May;5(5):1115-24.
10
Fibronectin secretion from human peritoneal tissue induces Mr 92,000 type IV collagenase expression and invasion in ovarian cancer cell lines.人腹膜组织分泌的纤连蛋白可诱导卵巢癌细胞系中92,000型IV型胶原酶的表达及侵袭。
Cancer Res. 1997 Dec 1;57(23):5416-20.

引用本文的文献

1
Targeting RNA-Polymerase I in Both Chemosensitive and Chemoresistant Populations in Epithelial Ovarian Cancer.针对上皮性卵巢癌中对化疗敏感和耐药的人群中的 RNA 聚合酶 I。
Clin Cancer Res. 2017 Nov 1;23(21):6529-6540. doi: 10.1158/1078-0432.CCR-17-0282. Epub 2017 Aug 4.
2
Novel Suppressive Effects of Ketotifen on Migration and Invasion of MDA-MB-231 and HT-1080 Cancer Cells.酮替芬对MDA-MB-231和HT-1080癌细胞迁移和侵袭的新型抑制作用
Biomol Ther (Seoul). 2014 Nov;22(6):540-6. doi: 10.4062/biomolther.2014.081. Epub 2014 Nov 30.
3
Imaging CXCL12-CXCR4 signaling in ovarian cancer therapy.
成像 CXCL12-CXCR4 信号在卵巢癌治疗中的作用。
PLoS One. 2013;8(1):e51500. doi: 10.1371/journal.pone.0051500. Epub 2013 Jan 23.
4
Smoothened antagonists reverse taxane resistance in ovarian cancer. smoothened 拮抗剂逆转卵巢癌中的紫杉烷耐药性。
Mol Cancer Ther. 2012 Jul;11(7):1587-97. doi: 10.1158/1535-7163.MCT-11-1058. Epub 2012 May 2.
5
Stem cell pathways contribute to clinical chemoresistance in ovarian cancer.干细胞途径导致卵巢癌临床化疗耐药。
Clin Cancer Res. 2012 Feb 1;18(3):869-81. doi: 10.1158/1078-0432.CCR-11-2188. Epub 2011 Dec 5.
6
The biphasic role of NF-kappaB in progression and chemoresistance of ovarian cancer.NF-κB 在卵巢癌进展和化疗耐药中的双相作用。
Clin Cancer Res. 2011 Apr 15;17(8):2181-94. doi: 10.1158/1078-0432.CCR-10-3265. Epub 2011 Feb 21.
7
Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells.纤连蛋白通过MEK1-MAPK和PI3K-Akt信号通路激活卵巢癌细胞中基质金属蛋白酶-9的分泌。
Clin Exp Metastasis. 2000;18(5):423-8. doi: 10.1023/a:1010921730952.
8
High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma.高水平的基质金属蛋白酶-2(MMP-2)、基质金属蛋白酶-9(MMP-9)、膜型基质金属蛋白酶-1(MT1-MMP)和基质金属蛋白酶组织抑制因子-2(TIMP-2)信使核糖核酸(mRNA)与卵巢癌患者的不良生存率相关。
Clin Exp Metastasis. 1999;17(10):799-808. doi: 10.1023/a:1006723011835.
9
Metastatic and non-metastatic colorectal cancer (CRC) cells induce host metalloproteinase production in vivo.转移性和非转移性结直肠癌(CRC)细胞在体内可诱导宿主产生金属蛋白酶。
Clin Exp Metastasis. 1999 Jun;17(4):341-9. doi: 10.1023/a:1006651019335.